Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid LeukemiaShanshan Pei, Craig T. Jordan, Anna Krug et al.|Cancer Discovery|2020Cited by 550
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapyMegan M. Tu, Dan Theodorescu, Hany Abdel-Hafiz et al.|Communications Biology|2020Cited by 170
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapyMegan M. Tu, Dan Theodorescu, Francis Y. F. Lee et al.|Science Advances|2019Cited by 126
ImmGen at 15Andrew L. Doedens, Stephanie Vargas Aguilar, Oscar A. Aguilar et al.|Nature Immunology|2020Cited by 79
Respiratory viral infections awaken metastatic breast cancer cells in lungsShi B. Chia, James DeGregori, Bryan Johnson et al.|Nature|2025Cited by 55